- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Caribou King Resources Set to Develop Graphene Process with Ortech Inc.
Caribou King Resources (TSXV:CKR,FWB:CB8) and Ortech Inc. are set to jointly develop technologies related to the production of commercial quality and economic graphene product. Under the joint development arrangement, Ortech will complete preliminary research and a first phase bench test of a process to develop graphene from high-grade graphite in exchange for $120,000 within 60 days from Caribou King Resources.
As quoted in the press release:
Under the joint development arrangement, Ortech will develop and test a process to develop graphene from high-grade graphite. Ortech will complete preliminary research and a first phase bench test of the process in consideration for $120,000, to be paid by Caribou within 60 days (alternatively, if Caribou does not wish to proceed with the test, it can terminate the arrangement for a fee of $25,000). If warranted, Ortech will: (a) complete a second phase bench test of the process in consideration of an additional $250,000; and (b) construct a pilot plant to test the process for $2.5 million, at which stage Caribou will own 49.0% of the technology underlying the process. Further, after six consecutive months of operation of such pilot plant, Caribou should desire to purchase Ortech’s interest in the technology (such that Caribou would be the sole owner of the technology), Caribou has the option, but not the requirement, to purchase such interest for $15 million, for a period of three months.
Click here to read the Caribou King Resources (TSXV:CKR,FWB:CB8) press release
Click here to see the Caribou King Resources (TSXV:CKR,FWB:CB8) profile.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â